For your condition
The report matters more than the mirror.
For most of our members, weight is the mechanism behind a second diagnosis. Here is what a supervised 10–15% reduction does to each of them, and what the evidence says.
01 — Condition
PCOS
Insulin resistance drives the cycle. Weight loss interrupts it.
- GLP-1 therapy improves insulin sensitivity, lowering the hyperinsulinaemia that drives ovarian androgen production.
- Reduced androgen load improves cycle regularity, acne and hirsutism over 4–6 months.
- Our programme pairs therapy with protein-forward nutrition and resistance training to protect lean mass.
Evidence
5–10%
body-weight loss can restore ovulatory cycles (ESHRE/ASRM guidance)
"My cycles had been irregular for nine years. Four months in, they are predictable again and I am down 11 kg."
Ritika S., 34
Gurugram · PCOS · 11 kg lost
02 — Condition
Fatty Liver (NAFLD)
Liver fat responds to weight loss faster than almost any other marker.
- Weight reduction lowers hepatic fat fraction and ALT/AST within 12–16 weeks.
- GLP-1 receptor agonists reduce hepatic de novo lipogenesis and improve insulin signalling.
- We track liver enzymes and fibrosis scores through monthly at-home labs.
Evidence
≥10%
weight loss resolves steatohepatitis in up to 90% of patients (Vilar-Gomez et al.)
"Grade 2 fatty liver on my ultrasound was the wake-up call. My ALT is back in range and I've lost 14 kg."
Anand M., 41
Mumbai · NAFLD · ALT 78 → 31 U/L
03 — Condition
Breathlessness & Sleep Apnoea
Less weight on the chest and airway means measurably easier breathing.
- Reduced visceral and neck adiposity improves upper-airway patency and lowers night-time desaturation.
- Patients report easier stair climbing and lower resting heart rate within 8 weeks.
- We screen with a validated sleep questionnaire and refer for polysomnography when indicated.
Evidence
−45%
reduction in apnoea-hypopnoea index with tirzepatide (SURMOUNT-OSA)
"I used to stop twice climbing to the second floor. Now I carry groceries up without noticing."
Suresh K., 45
Pune · Sleep apnoea · CPAP pressure reduced
04 — Condition
Prediabetes
The window where progression to type 2 diabetes is still reversible.
- Glucose-dependent insulin secretion and slowed gastric emptying flatten post-meal spikes.
- CGM data lets your doctor see exactly which Indian meals spike you, and adjust.
- Sustained 7% weight loss substantially reduces conversion to type 2 diabetes.
Evidence
−1.2%
average HbA1c reduction alongside weight loss in GLP-1 trials
"My HbA1c was 6.4%. My endocrinologist called it the last exit. Six months later it is 5.5%."
Meera J., 38
Bengaluru · Prediabetes · HbA1c 6.4 → 5.5%
Diagnostics
Your doctor may recommend one of these panels.
Free home sample collection, reports in 24–48 hours, and every result interpreted by a Metaboliq endocrinologist.
Metabolic Baseline
Start here: the core panel every weight-loss journey should begin with.
₹1,299₹2,600
Free home collection
Insulin Resistance + Fatty Liver Panel
Insulin resistance and NAFLD travel together — this panel quantifies both.
₹1,999₹3,900
Free home collection
Hormone & PCOS Panel
Weight that won't move is often hormonal. This panel finds out.
₹2,499₹4,800
Free home collection
GLP-1 Readiness Complete
The complete pre-therapy workup — everything your endocrinologist needs to prescribe GLP-1 safely and set your baseline.
₹3,499₹6,900
Free home collection
Start here
Bring your reports. We'll read them.
₹49 endocrinologist consult, refunded in full if GLP-1 therapy is not appropriate for you.
Individual results vary. Testimonials describe individual experiences and are not a guarantee of outcome. Statistics cited are from published clinical literature in the general study populations described.